Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
According to the Summary of Product Characteristics (SmPC), these include: Nausea (very common: may affect more than 1 in 10 people) Diarrhoea and constipation (very common) Vomiting and abdominal pain (very common) Decreased appetite and dyspepsia (very common) Most gastrointestinal adverse effects are mild to moderate in severity and tend to diminish over time as the body adjusts to treatment
Following a virtual screening of the SPECS database, along with enzymatic activity experiments, 17 novel compounds were created
PEPCID is the original brand with the active ingredient famotidine which is a histamine-2 blocker (H2 blocker) that provides relief for occasional heartburn.
Semaglutide, under the brand name Wegovy, is available in the following doses for weight management: 0.25mg 0.5mg 1mg 1.7mg 2.4mg Treatment typically begins with a 0.25mg dose, which is increased every 4 weeks until the maximum tolerated dose or the 2.5mg target dose is reached
100 St 0,18 / 1 St
A calculator cannot confirm the identity or safety of a vial
US$ 21.67
US$ 24.25
US$ 23.41
US$ 28.56
US$ 25.08
